BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36631883)

  • 1. Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
    Aseel A; McCarthy P; Mohammed A
    J Neuroimaging; 2023 Mar; 33(2):189-201. PubMed ID: 36631883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    Chuang MT; Liu YS; Tsai YS; Chen YC; Wang CK
    PLoS One; 2016; 11(1):e0141438. PubMed ID: 26741961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Elias AE; Carlos RC; Smith EA; Frechtling D; George B; Maly P; Sundgren PC
    Acad Radiol; 2011 Sep; 18(9):1101-8. PubMed ID: 21820634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
    Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
    AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
    Kinoshita K; Tada E; Matsumoto K; Asari S; Ohmoto T; Itoh T
    AJNR Am J Neuroradiol; 1997 Oct; 18(9):1753-61. PubMed ID: 9367328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis.
    Li H; Duan Y; Liu N; Dong J; Liang Y; Ju R
    Int J Clin Pract; 2022; 2022():1629570. PubMed ID: 36380750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients, and image-guided histopathology with special attention to radiation necrosis.
    Rock JP; Scarpace L; Hearshen D; Gutierrez J; Fisher JL; Rosenblum M; Mikkelsen T
    Neurosurgery; 2004 May; 54(5):1111-7; discussion 1117-9. PubMed ID: 15113465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo differentiation of aerobic brain abscesses and necrotic glioblastomas multiforme using proton MR spectroscopic imaging.
    Lai PH; Weng HH; Chen CY; Hsu SS; Ding S; Ko CW; Fu JH; Liang HL; Chen KH
    AJNR Am J Neuroradiol; 2008 Sep; 29(8):1511-8. PubMed ID: 18499784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
    Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.
    Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Bonavita S; de Cristofaro M; Conforti R; Cristofano A; Colonnese C; Salvolini U; Tedeschi G
    Radiol Med; 2014 Aug; 119(8):616-24. PubMed ID: 24408041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Dimensional magnetic resonance spectroscopic imaging at 3 Tesla for early response assessment of glioblastoma patients during external beam radiation therapy.
    Muruganandham M; Clerkin PP; Smith BJ; Anderson CM; Morris A; Capizzano AA; Magnotta V; McGuire SM; Smith MC; Bayouth JE; Buatti JM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):181-9. PubMed ID: 24986746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
    Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of magnetic resonance spectroscopy for the differentiation of recurrent glioma from radiation necrosis: a systematic review and meta-analysis.
    Zhang H; Ma L; Wang Q; Zheng X; Wu C; Xu BN
    Eur J Radiol; 2014 Dec; 83(12):2181-2189. PubMed ID: 25452098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
    Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
    Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.